News & Events

• April 4, 2014
  

  C-Path’s CEO, Martha A. Brumfield, featured on FasterCures blog

• January 8, 2014
  

  FDA releases Guidance for Drug Development Tool Qualification

• January 8, 2014
  

  EMA updates guidance for Qualification of Novel Methodologies for Drug Development

• December 2, 2013
  

  C-Path’s Alzheimer’s Disease Simulator Featured in the Wall Street Journal

• September 10, 2013
  

  C-Path cosponsors Alzheimer’s workshop

  C-Path cosponsors workshop on combination drug development for Alzheimer’s disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. The primary goal of this meeting held in Baltimore, MD November 29th 2012 was to explore how......